A Study to Evaluate Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of JNJ-64179375 in Healthy Male Subjects
Clinical trial NCT02949206 · COMPLETED
Trial details
- NCT number
- NCT02949206
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-14
- Primary completion
- 2017-08-09
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.